|
Research and Clinical Trials
We live in an exciting
time for cancer care. Due to many advances in medical and biotechnology
sciences, and recent breakthroughs in understanding the human genetic
code, there are more novel anti-cancer drugs in development today
than ever before.
The role of the community oncologist is critical
in testing and rapidly bringing these advances to patients. However,
most community practices do not have the scale or resources to build
an active research program.
Through Comprehensive Cancer Centers of Nevada
(CCCN), patients can take part in exciting new clinical trials and
novel therapies—right in their own communities. We are a primary
participant in the nationwide US
Oncology Research Network, made up of 170 research locations
with an experienced staff of more than 300 dedicated research professionals.
CCCN also provides patients in the Las Vegas
area access to state-of-the-art cancer research trials, through
affiliations with Jonsson Comprehensive Cancer Center (JCCC) at
UCLA, Translational Oncology Research International (TORI), and
Community Clinical Oncology Program (CCOP). To learn more about
CCCN’s affiliation with these leading clinical oncology research
organizations, click here.
Through this highly efficient organization,
new drugs and therapies are sped from the research lab into the
real world, reaching patients as quickly as possible. Eleven anticancer
drugs have received FDA approval, largely due to the work of the
US Oncology research program.
Access to this extensive network of research
and clinical trials gives cancer patients the added advantage of
cutting-edge expertise and treatments that may shrink their tumors
or alleviate their symptoms.
|
